Daiichi Sankyo (DSNKY) Expected to Announce Earnings on Monday

Daiichi Sankyo (OTCMKTS:DSNKY) is expected to release its resultson Monday, April 27th. Analysts expect Daiichi Sankyo to post earnings of $0.3721 per share and revenue of $3.8155 billion for the quarter.

Daiichi Sankyo (OTCMKTS:DSNKY) last released its quarterly earnings data on Thursday, January 29th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.05. The business had revenue of $3.65 billion for the quarter, compared to analyst estimates of $3.88 billion. Daiichi Sankyo had a return on equity of 18.64% and a net margin of 14.83%. On average, analysts expect Daiichi Sankyo to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Daiichi Sankyo Stock Performance

OTCMKTS:DSNKY opened at $15.56 on Friday. The stock’s 50-day simple moving average is $18.31 and its 200 day simple moving average is $21.01. The firm has a market capitalization of $29.48 billion, a PE ratio of 14.28, a price-to-earnings-growth ratio of 0.90 and a beta of -0.04. Daiichi Sankyo has a twelve month low of $15.56 and a twelve month high of $28.21. The company has a quick ratio of 1.85, a current ratio of 2.69 and a debt-to-equity ratio of 0.18.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.